Home » Topics » BioWorld Science

BioWorld Science
RSS

COQ8B acts as a modifier of thoracic aortic aneurysm severity

Nov. 19, 2018

SY-5609 selected for development from novel selective CDK7 inhibitor series

Nov. 19, 2018

Phase II trial explores whether EDP-1503 enhances response to pembrolizumab in advanced melanoma

Nov. 19, 2018

PDE9 inhibition with CRD-733 shows promise for heart failure

Nov. 19, 2018

Data presented on BRM-inhibiting ureas as potential anticancer agents

Nov. 19, 2018

Kiss of death: tumor cells suck calcium from bone cells to metastasize

Nov. 19, 2018

PsiOxus and Parker Institute collaborate on virus-based gene therapy to treat solid tumors

Nov. 16, 2018

Apolipoprotein D as a potential new target in Niemann-Pick type A disease

Nov. 16, 2018

Biohaven initiates phase III trial of rimegepant for preventive treatment of migraine

Nov. 16, 2018

uniQure reports initial phase IIb data on AMT-061 for hemophilia B

Nov. 16, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...